Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
-489K
-
Total reported value, excl. options
-
$83M
-
Value change
-
-$3.24M
-
Put/Call ratio
-
1.7
-
Number of buys
-
12
-
Number of sells
-
-18
-
Price
-
$6.90
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q3 2014
44 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q3 2014.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 29.5M outstanding shares and own 40.73% of the company stock.
Largest 10 shareholders include FMR LLC (2.97M shares), ORBIMED ADVISORS LLC (1.92M shares), Visium Asset Management, LP (1.66M shares), JPMORGAN CHASE & CO (1.35M shares), FRANKLIN RESOURCES INC (1.1M shares), DEERFIELD MANAGEMENT CO (1.01M shares), VANGUARD GROUP INC (500K shares), SABBY MANAGEMENT, LLC (264K shares), Tekla Capital Management LLC (244K shares), and EVENTIDE ASSET MANAGEMENT, LLC (202K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.